Faced with skyrocketing costs for developing new drugs, researchers are looking at ways to repurpose older ones — and even some that failed in initial trials.
Read the full article at: www.nature.com
This is a great piece for insurance carriers!
Faced with skyrocketing costs for developing new drugs, researchers are looking at ways to repurpose older ones — and even some that failed in initial trials.
Read the full article at: www.nature.com
This is a great piece for insurance carriers!